Ifeanyichukwu Ifechidere: Coagulation Fundamentals for Result Interpretation in Clinical Practice
Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post on LinkedIn:
“From lost in the MDT… to adding real clinical value
I still remember my first MDT meeting as a newly qualified biomedical scientist.
I walked in thinking: ‘I know my coagulation. I’ll be fine’
Within minutes…Ahh, I was completely lost.
The room was filled with consultants, haematologists, nurses, pharmacists – speaking a language that sounded familiar, but somehow not the same as what I’d learned in the lab.
They weren’t talking about ‘results.’
- ‘Recurrent VTE despite anticoagulation…’
- ‘Possible underlying malignancy…’
- ‘Inflammatory markers trending up…’
And I sat there thinking:
My God! Where does my APTT result fit into all of this?
But here is my turning point
What changed wasn’t my technical knowledge.
It was my perspective.
I started asking different questions:
Why was this test requested?
What decision is this result influencing?
What could make this result misleading?
Suddenly, coagulation wasn’t just numbers – it was context.
From reporting results to interpreting meaning
Instead of just releasing results, I began to notice patterns:
- A short APTT in a patient with inflammation – could this reflect elevated factor VIII?
- Low fibrinogen by Clauss – interference or true deficiency?
- Unexpected results – do they fit the clinical picture?
And slowly… I started speaking up.
The first time I contributed
I still remember the moment, that quite confident.
A case was being discussed with ‘low fibrinogen.’
Something didn’t add up.
I hesitated… then said:
‘Could this be assay interference rather than true hypofibrinogenaemia?’
The room paused.
Then someone nodded.
Then the discussion shifted.
And just like that – I wasn’t invisible anymore.
Where I am now
Today, I don’t just attend MDTs – I contribute.
I flag potential interferences
I provide interpretive comments
I help connect lab data to clinical decisions
Because biomedical scientists aren’t just behind – the – scenes.
We are part of the clinical decision – making process.
I have been there
Feeling lost at the start doesn’t mean you don’t belong.
It means you’re learning to think clinically, not just analytically.
And that’s where real impact begins.
Want more insights to help you bridge the gap between lab science and clinical practice?
Subscribe for updates and pick up your well built course on coagulation fundamental in result interpretation.”
Other posts featuring Ifeanyichukwu Ifechidere on Hemostasis Today.
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH